Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.16)
# 503
Out of 5,030 analysts
85
Total ratings
42.35%
Success rate
19.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $400 → $540 | $438.90 | +23.03% | 4 | Oct 15, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $15.66 | +398.08% | 1 | Oct 6, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $65 → $48 | $47.90 | +0.21% | 2 | Sep 11, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $6.66 | +200.30% | 1 | Sep 8, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $81 → $15 | $9.92 | +51.21% | 4 | Aug 28, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.85 | +436.08% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.57 | +154.78% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $6.58 | +1,085.41% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $65.47 | +121.48% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $15.06 | +238.76% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $6 | $1.42 | +322.54% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $15.35 | +212.70% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $63.14 | +47.29% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $20.96 | +257.91% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $57.77 | +81.76% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $36.40 | +1.65% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $3.21 | +709.97% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.80 | +3,398.69% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $41.57 | +133.34% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $189.99 | +42.11% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $17.26 | +340.32% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.83 | +552.74% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $15.63 | +91.94% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.74 | +109.06% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.71 | +1,810.83% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $42.15 | +327.05% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.19 | +584.93% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.61 | +343.21% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $34.63 | +131.01% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $27.38 | +239.66% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $17.51 | +225.53% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.36 | +810.33% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $77.50 | -54.84% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $11.01 | +690.19% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $9.99 | +1,651.75% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $58.44 | +23.20% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $14.76 | +28.73% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $3.92 | +1,175.51% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.81 | +2,109.94% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.35 | +5,042.86% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $19.79 | +2,022.28% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $20.66 | +272.70% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $73.53 | +4.72% | 1 | Jul 31, 2020 |
Madrigal Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $400 → $540
Current: $438.90
Upside: +23.03%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $15.66
Upside: +398.08%
Tourmaline Bio
Sep 11, 2025
Downgrades: Neutral
Price Target: $65 → $48
Current: $47.90
Upside: +0.21%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $6.66
Upside: +200.30%
Prothena Corporation
Aug 28, 2025
Maintains: Overweight
Price Target: $81 → $15
Current: $9.92
Upside: +51.21%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.85
Upside: +436.08%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.57
Upside: +154.78%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $6.58
Upside: +1,085.41%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $65.47
Upside: +121.48%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $15.06
Upside: +238.76%
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.42
Upside: +322.54%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $15.35
Upside: +212.70%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $63.14
Upside: +47.29%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $20.96
Upside: +257.91%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $57.77
Upside: +81.76%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $36.40
Upside: +1.65%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $3.21
Upside: +709.97%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.80
Upside: +3,398.69%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $41.57
Upside: +133.34%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $189.99
Upside: +42.11%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $17.26
Upside: +340.32%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.83
Upside: +552.74%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $15.63
Upside: +91.94%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.74
Upside: +109.06%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.71
Upside: +1,810.83%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $42.15
Upside: +327.05%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.19
Upside: +584.93%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.61
Upside: +343.21%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $34.63
Upside: +131.01%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $27.38
Upside: +239.66%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $17.51
Upside: +225.53%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.36
Upside: +810.33%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $77.50
Upside: -54.84%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $11.01
Upside: +690.19%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $9.99
Upside: +1,651.75%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $58.44
Upside: +23.20%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $14.76
Upside: +28.73%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $3.92
Upside: +1,175.51%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.81
Upside: +2,109.94%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.35
Upside: +5,042.86%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $19.79
Upside: +2,022.28%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $20.66
Upside: +272.70%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $73.53
Upside: +4.72%